Strategic Investment & Partnership Platform

Connecting Ideas,

Capital and

Opportunities.

Leapsun Partners builds bridges between innovation, capital, and global market opportunities — with a focus on healthcare, biotechnology, advanced technology, and consumer health across Asia-Pacific.

Scroll to explore
About Leapsun

A New Paradigm in Strategic Partnership

Leapsun Partners (Leapsun Partners Pte. Ltd., Singapore) is a strategic investment and partnership platform headquartered in Singapore. The firm focuses on connecting capital, talent, and market access across healthcare, biotechnology, advanced technology, and consumer health sectors in the Asia-Pacific region and European markets.

30+
Years of Experience
50+
Global Partners
5
Focus Sectors
Strategic partnership
Leapsun Partners · Singapore
"

Connecting Ideas, Capital and Opportunities.

Core Mission
Our Expertise

Where We Create Value

Five domains where we identify, connect and accelerate transformative opportunities.

01

Healthcare

Investing in next-generation healthcare systems and medical innovation across emerging markets.

02

Biotechnology

Partnering with pioneering biotech ventures transforming life sciences and therapeutics.

03

Emerging Technology

Identifying and accelerating high-potential technology opportunities shaping tomorrow.

04

Cross-border Investments

Facilitating capital flows and strategic alignments across international markets.

05

Strategic Partnerships

Forging alliances between corporates, governments, and innovators to unlock shared potential and create powerful synergies across borders and industries.

Portfolio

Strategic Focus Across Innovation Frontiers

Pioneering companies that reshape their industries through technological innovation, clinical insight, and data-driven precision.

8 Companies
Healthcare & Longevity Tech
1
Category 1

Healthcare & Longevity Tech

Technology-driven companies aligned with regulatory pathways, clinical application, and long-term public health goals.

Angelexo

Angelexo

安杰莱科技
Brain-Computer Interface & Neuro-Rehab Robotics

Pioneers non-invasive brain-computer interface (BCI) technology integrated with neuro-rehabilitation robotics. Developing intelligent human-machine interaction systems that decode neural signals to drive motor rehabilitation for stroke survivors and neurological disorder patients. Translates cutting-edge BCI science into clinical-grade recovery solutions.

Pegbio

Pegbio

派格生物
Long-Acting Biologics

Targets diabetes, obesity, and metabolic disease with differentiated long-acting GLP-1 receptor agonists. Core product PB-119 is NDA-stage, leading China's innovative approach to chronic disease prevention.

BDgene

BDgene

本导基因
In Vivo CRISPR Gene Editing

Pioneers in vivo CRISPR/Cas9 gene editing via proprietary VLP and lentiviral delivery platforms. Lead program BD111 — the world's first CRISPR antiviral therapeutic targeting herpetic stromal keratitis — holds FDA IND clearance, Phase II clinical status, and EU Orphan Drug Designation.

Advanced Technology & Industrial Intelligence
2
Category 2

Advanced Technology & Industrial Intelligence

Foundational technologies enabling national digital infrastructure, industrial upgrading, and operational resilience.

Minisilicon

Minisilicon

米硅科技
Optical Communication Chips

Develops high-speed, high-reliability chips for optical communication and data centers. Supports 400G+ data infrastructures essential for cloud computing and AI scalability.

Hawkeyes

Hawkeyes

禾楷电气
Laser Detection for Power & Industrial Equipment

Self-developed laser detection technology backed by a certified cleanroom photonics lab and multiple invention patents. Serves substations and large industrial enterprises with online monitoring instruments, fault early-warning systems, and end-to-end condition-based maintenance solutions.

SurMeta

SurMeta

申美信息
Making Digital Transformation Verifiable

Drives enterprise intelligence with AI, large models, data intelligence, software engineering, digital twins, AIoT and cloud infrastructure. Delivers industry-specific solutions across finance, automotive, telecom, energy, manufacturing and consumer sectors.

New Consumer & Digital Commerce
3
Category 3

New Consumer & Digital Commerce

Digital-native operators positioned as the intelligent backbone of China's evolving consumer economy.

Keying

Keying

凯诘电商
Full-Stack E-Commerce Operations

China's fifth-largest digital retail solutions provider by GMV. End-to-end services from traffic to fulfillment for 200+ global brands across Tmall, JD.com, Douyin, and Pinduoduo.

Sensilab

Sensilab

尚生力
Vision Healthcare — EU Nutrition Supplement Group

Sensilab is a core brand of Vision Healthcare — the EU's leading nutrition supplement group, headquartered in the Netherlands. Built on evidence-based formulations and strong digital marketing channels, Sensilab serves tens of millions of customers across 45+ countries with a portfolio spanning vitamins & minerals, weight management, and functional health products. Leapsun is a long-term strategic partner driving Sensilab's premium range into the Asia-Pacific and China markets.

Common Traits
Niche but Scalable
Each company addresses a specific unmet need with potential for broad, long-term market adoption.
Tech-Centric with Operational Depth
From chips to biotech, the portfolio emphasizes execution — not just vision.
Strategically Relevant
Focused on longevity, data, and efficiency — three defining themes of the coming decades.
Consultancy

AI, Healthcare & E-commerce Advisory

A dedicated advisory practice drawing on our operating foundation, senior relationships and broad industry experience across AI, life sciences, cross-border commerce and aviation.

Built on our operating base

AI & Globalization Strategy

Go-to-market and cross-border expansion advisory for AI-driven enterprises and consumer brands, drawing on our operating foundation, broad industry experience, and our Singapore, Shanghai and European network.

01

Enterprise AI & data intelligence

Turning AI, large models, data intelligence and cloud engineering into measurable business outcomes across finance, automotive, telecom, energy, manufacturing and consumer sectors.

02

Cross-border e-commerce

Full-chain go-to-market for brands entering Asia and China — from traffic and platform operations to order fulfilment across Tmall, JD, Douyin and other digital retail channels, with market-access and distribution partnerships.

Built on our operating base

Healthcare & Life Sciences

Cross-border partnering and market-entry advisory for healthcare and life-science innovators, from medical devices to novel therapeutics, drawing on our operating foundation and broad industry experience.

01

Neurotechnology & medical devices

Taking non-invasive brain–computer interface and neuro-rehabilitation robotics from scientific breakthrough to clinical-grade solutions and industrial-scale deployment.

02

Biopharma & life sciences

Cross-border partnering, licensing and market-access strategy for long-acting biologics, gene-editing therapies and other innovative medicines.

Also advising in
Aviation

Advisory for aviation businesses and cross-border aviation partnerships, together with our partners Swiss Aviation Group and Slovenia Aviation Academy.

  • Fleet planning
  • Aviation training
  • Cross-border aviation partnerships
How we work
  1. 01

    Scope

    Define objectives, constraints and target markets together with the client.

  2. 02

    Align

    Bring in the right partners and formalize the working framework, including MOUs where appropriate.

  3. 03

    Structure

    Design the operating and partnership structure of the engagement, working alongside the client's own legal and regulatory advisers.

  4. 04

    Execute

    Support delivery, introductions and follow-through to a measurable result.

Additional advisory verticals available through our partner network — inquire directly.

The advisory services described here are strategic and operational in nature. They do not constitute financial, investment, legal or tax advice, and nothing on this page is an offer or solicitation of any financial product or service.

Our Vision

A trusted bridge between Asia and the world's leading innovators.

We believe lasting progress in health and technology comes from patient partnerships built on trust, expertise and respect for local markets. We aim to help great ideas travel across borders, and to grow with the people who carry them.

Insights

Perspectives on Global Growth

The GLP-1 Revolution: Long-Acting Biologics and the Race to Redefine Metabolic Medicine
Healthcare
The 400G+ Race: Optical Communication Chips as the Unseen Engine of AI Infrastructure
Deep Tech
China's 2025 Consumption Recovery: Why Full-Stack E-Commerce Operations Are the New Infrastructure Play
Investment
Europe–Asia Health Brands: Pathways into China's $70B Premium Wellness Market
Markets
Get In Touch

Let's Build the Future Together

We're always looking for exceptional partnerships. Reach out to explore how we can work together.

Singapore
100 Peck Seah Street, PS100 #08-14
Singapore 079333
Shanghai
上海市新金桥路1122号方正大厦1912室
上海 201206